Beeline Holdings (NASDAQ: BLNE) provided a preliminary update on third-quarter 2026 performance, expecting revenue to reach the second-highest quarterly level in company history and the highest since 2021, while achieving its highest margins to date. Beeline also expects its net

Datavault AI (NASDAQ: DVLT) appointed Christopher R. Hardt to its board of directors as an independent director, effective Oct. 3, 2026. Hardt, who was designated by NYIAX in connection with Datavault AI recently completed acquisition, previously served on the NYIAX

A2Z Cust2Mate Solutions Corp. (NASDAQ: AZ) has completed its acquisition of Hedia, an Israeli retail media company with fiscal 2025 audited revenue of approximately $20 million. The acquisition combines A2Z Cust2Mate smart cart technology, digital in-store retail media inventory, shopper

Disseminated on behalf of BTQ Technologies Corp. and may include paid advertisements.

Kairos Pharma (NYSE American: KAPA) announced positive interim efficacy data from its ongoing Phase 2 trial evaluating ENV-105 in combination with apalutamide in patients with metastatic castration-resistant prostate cancer. The analysis showed a statistically significant difference in progression-free survival, with

This article has been disseminated on behalf of Silvercorp Metals and may include paid advertising.

Healthcare and diagnostics operators are facing consolidation pressure, reimbursement uncertainty and more selective sponsors all at once. In that environment, how a capital raise is structured can matter as much as the business behind it. Market Street Capital is a boutique capital

Disseminated on behalf of Lahontan Gold Corp. and may include paid advertising.

OpenAI has decided against releasing a new artificial intelligence system after internal testing revealed problems with how reliably and safely it could operate. The system, known as GPT-6.1 Astra, was designed to work more independently than a conventional chatbot, including browsing the

Surgeons can now identify a brain tumor’s genetic makeup before a patient even leaves the operating table, cutting what used to be an eight-week wait for diagnosis down to about two hours. The Brain Tumor Research Center of Excellence at the

The price of copper declined as the week drew to a close amid rising crude oil prices and a strengthening dollar. These two headwinds exerted downward pressure on most industrial metals. On Thursday alone, LME copper lost 1% to sell

Oncotelic Therapeutics (OTCQB: OTLC), together with its wholly owned subsidiary Pet2DAO, Inc., announced that its PDAOAI artificial intelligence-powered drug discovery platform is inviting scientists, AI developers and biotech founders to participate in BIO REBOOT. Participants can bring research questions, technical

NanoViricides, Inc. (NYSE American: NNVC), a clinical-stage company developing antiviral drugs, provided additional details on its Phase II clinical trial of NV-387 Oral Gummies for treatment of the current Bundibugyo Ebolavirus “BDBV” outbreak and other Ebola viruses in the Democratic

Silynxcom (NYSE American: SYNX), a manufacturer and developer of ruggedized tactical communication and hearing-protection devices, as well as other gear and accessories, recently announced that it received two consecutive purchase orders from a leading global defense company, totalling around $400,000

This article has been disseminated on behalf of Shelfie-Tech Ltd. and may include paid advertising. 

Rezolve Ai (NASDAQ: RZLV), a global leader in AI-powered commerce and engagement, announced a worldwide reseller agreement with Mastercard, authorizing Mastercard to market, offer and sell subscriptions to Rezolve Ai software and SaaS services worldwide on a non-exclusive basis. Mastercard

Apimeds Pharmaceuticals US, Inc. (NYSE American: APUS) subsidiary MindWave Innovations Inc. USA signed a two-year master maintenance and service agreement with BlockAssure Inc. to build, deploy and operate AssureChain, a dedicated subnet of MindChain for BlockAssure insurance and reinsurance operations.

HeartBeam (NASDAQ: BEAT), a medical technology company focused on transforming cardiac care, received U.S. Food and Drug Administration “FDA” Breakthrough Device Designation for the HeartBeam System as a tool for assessing potential heart attacks at home. The designation recognizes the

This article has been disseminated on behalf of LaFleur Minerals and may include paid advertising. 

Greenland Mines (NASDAQ: GRML; FSE: HK6), a Greenland-focused critical-minerals development company, exercised in full its option to acquire an additional 9.9% of AnorTech, increasing its ownership to 19.9%. Greenland Mines will acquire 25,168,669 AnorTech common shares at a deemed price